Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 71  |  Page : 620-624

Naringenin reduced migration in osteosarcoma cells through downregulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and snail


1 Department of Neurology, Division of Internal Medicine, Hsinchu Mackay Memorial Hospital, Hsinchu; Institute of Biochemistry, Microbiology, and Immunology, Chung Shan Medical University, Taichung, Taiwan
2 Department of Internal Medicinel; School of Medicine, Chung Shan Medical University, Taichung, Taiwan
3 Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan
4 Institute of Biochemistry, Microbiology, and Immunology, Chung Shan Medical University, Taichung, Taiwan
5 Department of Cosmeceutics, College of Biopharmaceutical and Food Sciences, China Medical University; Department of Health and Nutrition Biotechnology, Asia University; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan
6 Department of Parasitology, School of Medicine, Chung Shan Medical University, Taichung, Taiwan
7 Institute of Biochemistry, Microbiology, and Immunology; Clinical Laboratory, Chung Shan Medical University Hospital, Taichung, Taiwan
8 Division of Functional Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung; Department of Neurosurgery, Lin Shin Medical Corporation Lin Shin Hospital, Taichung, Taiwan

Correspondence Address:
Li-Sung Hsu
Institutes of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, No. 110, Sec. 1, Jianguo N. Road, Taichung 40201
Taiwan
Ting-Hsien Kao
Department of Neurosurgery, Lin Shin Medical Corporation Lin Shin Hospital , No. 36, Section 3 Huizhong Road, Taichung, 40862
Taiwan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_31_20

Rights and Permissions

Background: Osteosarcoma is one of the most malignant cancers in children. Naringenin exhibits several cellular functions. Objectives: In this study, we investigate the effects of naringenin on osteosarcoma. Materials and Methods: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to detect the cell viability. Zymography assay and transwell assay were used to measure the matrix metalloproteinase (MMP) activity and migration ability. Western blot analysis was used to determine the expression of migration-related proteins. Results: No overt alternation of cytotoxicity in response to different concentrations of naringenin for 24 h was found by MTT assay. MMP-2 and MMP-9 activities and expression were significantly repressed by naringenin in a dose-dependent manner, as evidenced by zymography and Western blot analysis. Naringenin dose dependently reduced the expression of mesenchymal marker Snail. Conclusion: These results indicate that naringenin exhibited antimigration property through inhibition of MMP-2 and MMP-9 and downregulation of Snail expression. Thus, naringenin may be a potential inhibitor of metastasis of osteosarcoma.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed119    
    Printed0    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    

Recommend this journal